financetom
Business
financetom
/
Business
/
Sapiens Q2 revenue up 3.5%, beats expectations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sapiens Q2 revenue up 3.5%, beats expectations
Aug 13, 2025 4:52 AM

Overview

* Sapiens Q2 2025 rev rises 3.5% yr/yr, beating analysts' expectations

* Adjusted EPS and net income for Q2 beat consensus

* Co completed acquisitions of Advantage Go and Candella, boosting P&C and Life segments

Outlook

* Sapiens expects acquisitions to strengthen P&C and Life growth

* Company aims to accelerate cloud adoption and expand globally

* Sapiens focuses on platform innovation and cross-selling for growth

* Company sees growth catalysts in Life & Annuities expansion

Result Drivers

* STRATEGIC PRIORITIES - Co executed strategic priorities by securing new deals and strengthening customer relationships in Life, P&C, and Reinsurance segments, per CEO Roni Al-Dor

* ACQUISITIONS - Completed acquisitions of Advantage Go and Candella to strengthen P&C and Life growth

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $141.60 $140 mln

Revenue mln (4

Analysts

)

Q2 Beat $0.34 $0.32 (4

Adjusted Analysts

EPS )

Q2 EPS $0.25

Q2 Beat $19.30 $18.10

Adjusted mln mln (4

Net Analysts

Income )

Q2 Beat $23.10 $21.60

Adjusted mln mln (4

Operatin Analysts

g Income )

Q2 45.8%

Adjusted

Gross

Margin

Q2 $64.80

Adjusted mln

Gross

Profit

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the software peer group is "buy."

* Wall Street's median 12-month price target for Sapiens International Corporation NV ( SPNS ) is $31.00, about 4.8% above its August 12 closing price of $29.50

* The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 18 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Erayak Unveils New Innovation Hub Nexora Group, Stock Gains
Erayak Unveils New Innovation Hub Nexora Group, Stock Gains
Oct 17, 2025
Erayak Power Solution Group Inc. ( RAYA ) shares traded higher Friday after the company announced the launch of its U.S.-based subsidiary, Nexora Group Inc. The subsidiary will serve as its North American headquarters and a key pillar in its international expansion strategy. Nexora will coordinate sales, marketing, logistics, and localized product development for the U.S. and Canadian markets. Also...
Meta Platforms Adds Parental Controls for AI Characters
Meta Platforms Adds Parental Controls for AI Characters
Oct 17, 2025
08:28 AM EDT, 10/17/2025 (MT Newswires) -- Meta Platforms ( META ) said Friday that it is providing simple, new ways for parents to control how much interaction their children have with artificial intelligence characters. The company said the new features will allow parents to block their kids' access to one-on-one chats with AI characters entirely, or just block specific...
Summit Therapeutics Expands Phase III Ivonescimab Program Into Colorectal Cancer
Summit Therapeutics Expands Phase III Ivonescimab Program Into Colorectal Cancer
Oct 17, 2025
08:29 AM EDT, 10/17/2025 (MT Newswires) -- Summit Therapeutics ( SMMT ) said Friday it is initiating a phase III trial to evaluate bispecific antibody ivonescimab as a first line therapy in patients with unresectable metastatic colorectal cancer. The biopharmaceutical company said the trial represents a first global study of ivonescimab beyond non-small cell lung cancer. The phase III trial...
Starbucks Investors Call on Board to Resume Talks With Union
Starbucks Investors Call on Board to Resume Talks With Union
Oct 17, 2025
08:24 AM EDT, 10/17/2025 (MT Newswires) -- Starbucks ( SBUX ) shareholders led by New York City's pension funds and Trillium Asset Management have asked the board to resume talks with Starbucks Workers United and reach a first contract promptly. In their letter to the board Thursday, the investors expressed concern that labor relations at the company have significantly deteriorated...
Copyright 2023-2026 - www.financetom.com All Rights Reserved